Fig. 1: Proportion with detectable HPV-specific B-cell responses over time (per protocol cohort).
From: Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial
Bars represent 95% CI, and numbers are the number of participants with detectable responses.
